KROS - Balance Sheet - Keros Therapeutics, Inc.

Current Liabilities	27.4 M
Accounts Payable	4.6 M
Short-Term Debt	1.98 M
Other Current Liabilities	20.9 M
Non-Current Liabilities	16.9 M
Long-Term Debt	0
Other Non-Current Liabilities	16.9 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	559.9	331.1	279.0	230.0	265.9	7.0	23.3
Short Term Investments	0	0	0	0	0	0	0
Receivables	4.5	1.1	0.8	18.0	0.2	0.9	0
Inventory	0	0	(0.8)	3.1	1.5	0.8	0
Other Current Assets	1.5	15.1	5.9	3.2	1.6	1.0	2.3
Total Current Assets	588.9	347.3	285.8	251.4	267.7	8.9	25.5
PP&E	23.5	19.5	17.6	2.4	1.6	1.9	1.4
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	1.2	1.3	1.3	0.1	0.1	0.5
Other Long Term Assets	3.5	2.1	2.1	82 K	0	0	0
Other Assets	0	0	0	0	0	0	0
Total Assets	615.9	370.0	306.8	255.3	269.4	11.0	27.4
LIABILITIES
Accounts Payable	4.6	5.5	3.3	3.6	2.1	2.1	0.5
Short Term Debt	2.0	1.0	0.9	1.7	0.8	0.4	0.2
Other Current Liabilities	20.9	17.9	12.2	6.4	4.0	2.0	0.5
Total Current Liabilities	27.4	24.4	16.5	11.8	7.2	4.5	11.5
Long Term Debt	0	13.4	25.6	0.5	1.0	0.9	0.6
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	0	0	(12.8)	(0.2)	(0.4)	5.1	2.6
Total Liabilities	44.3	37.8	29.4	12.1	7.7	5.5	14.7
EQUITY
Common Stock	4 K	3 K	2 K	2 K	2 K	2 K	1 K
Retained Earnings	(568.8)	(381.4)	(228.4)	(123.8)	(65.0)	(19.6)	(7.3)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	(269.4)	(19.9)	(0.2)
Total Equity	571.6	332.2	277.4	243.2	261.7	5.5	12.8
Total Liabilities and Equity	615.9	370.0	306.8	255.3	269.4	11.0	27.4
SHARES OUTSTANDING
Common Shares Outstanding	37.4	29.4	25.2	23.3	15.5	8.9	8.9

Free